Balaxi Pharmaceuticals Ltd

₹ 24.5 0.20%

24 Jul - close price

About

Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines. ^[1]

Key Points

Product Portfolio:^[1]
The Co's portfolio includes a balanced mix of generic and branded generic medicines. The strongest product categories are Antibiotics (84 products), Analgesics (65 products), Medical Devices (32 products) and Vitamins **(26 products) **

Website NSE - BE

Market Cap ₹ 135 Cr.
Current Price ₹ 24.5
High / Low ₹ 52.5 / 15.2
Stock P/E 26.2
Book Value ₹ 24.1
Dividend Yield 0.00 %
ROCE 5.93 %
ROE 3.95 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Stock is trading at 1.02 times its book value
Company is expected to give good quarter
Company's working capital requirements have reduced from 193 days to 43.1 days

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -1.43% over past five years.
Company has a low return on equity of 3.44% over last 3 years.
Earnings include an other income of Rs.9.67 Cr.
Company has high debtors of 290 days.
Promoter holding has decreased over last 3 years: -6.70%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	30.35	25.04	16.55	12.70	15.90	19.03	21.16	11.16	9.65	16.71	19.31	24.59	20.24
	24.94	21.27	15.64	12.42	15.70	17.53	19.68	11.06	10.31	16.17	18.53	23.21	22.17
Operating Profit	5.41	3.77	0.91	0.28	0.20	1.50	1.48	0.10	-0.66	0.54	0.78	1.38	-1.93
OPM %	17.83%	15.06%	5.50%	2.20%	1.26%	7.88%	6.99%	0.90%	-6.84%	3.23%	4.04%	5.61%	-9.54%
	0.18	0.13	1.15	1.03	0.16	0.85	1.29	2.92	0.32	0.46	4.21	1.62	3.37
Interest	0.23	0.26	0.36	0.41	0.51	0.35	0.45	0.57	0.69	0.63	0.62	0.73	0.71
Depreciation	0.27	0.13	0.13	0.13	0.12	0.12	0.12	0.11	0.11	0.11	0.12	0.15	0.31
Profit before tax	5.09	3.51	1.57	0.77	-0.27	1.88	2.20	2.34	-1.14	0.26	4.25	2.12	0.42
Tax %	22.59%	27.35%	24.84%	36.36%	114.81%	27.13%	24.55%	25.21%	3.51%	23.08%	22.82%	27.83%	61.90%
	3.94	2.55	1.18	0.49	-0.58	1.38	1.66	1.74	-1.18	0.19	3.26	1.53	0.16
EPS in Rs	0.77	0.50	0.23	0.10	-0.11	0.25	0.30	0.32	-0.21	0.03	0.59	0.28	0.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.12	0.05	0.00	0.00	13.60	45.63	86.87	101.29	108.14	70.20	60.99	80.85
	0.08	0.11	0.13	0.77	12.05	36.98	67.85	83.99	91.26	64.78	58.38	80.09
Operating Profit	0.04	-0.06	-0.13	-0.77	1.55	8.65	19.02	17.30	16.88	5.42	2.61	0.76
OPM %	33.33%	-120.00%			11.40%	18.96%	21.89%	17.08%	15.61%	7.72%	4.28%	0.94%
	0.12	0.00	0.00	0.00	0.89	0.59	1.81	2.75	6.60	2.33	5.37	9.67
Interest	0.01	0.05	0.04	0.00	0.00	0.05	0.15	0.10	0.51	1.66	2.24	2.70
Depreciation	0.00	0.00	0.00	0.00	0.00	0.01	0.09	0.25	0.52	0.51	0.46	0.70
Profit before tax	0.15	-0.11	-0.17	-0.77	2.44	9.18	20.59	19.70	22.45	5.58	5.28	7.03
Tax %	26.67%	-36.36%	0.00%	0.00%	19.26%	29.30%	26.52%	25.53%	27.75%	34.59%	31.82%	26.74%
	0.10	-0.08	-0.17	-0.77	1.97	6.50	15.13	14.67	16.22	3.65	3.60	5.15
EPS in Rs	0.07	-0.05	-0.11	-0.51	1.30	1.30	3.03	2.93	3.19	0.67	0.65	0.93
Dividend Payout %	91.20%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.41%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	109%
5 Years:	-1%
3 Years:	-9%
TTM:	33%

Compounded Profit Growth
10 Years:	52%
5 Years:	-19%
3 Years:	-32%
TTM:	43%

Stock Price CAGR
10 Years:	20%
5 Years:	-27%
3 Years:	-38%
1 Year:	-50%

Return on Equity
10 Years:	12%
5 Years:	9%
3 Years:	3%
Last Year:	4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.04	3.04	3.04	3.04	3.04	10.00	10.00	10.00	10.18	10.90	11.04	11.04
Reserves	0.18	0.11	-0.72	-1.49	0.48	18.11	33.25	47.91	81.93	110.65	116.81	121.96
	0.00	0.20	0.00	0.00	0.00	0.00	3.51	1.93	12.44	15.70	32.18	35.30
	0.46	0.22	0.05	0.13	2.59	9.79	22.16	22.07	25.17	17.12	14.41	23.87
Total Liabilities	3.68	3.57	2.37	1.68	6.11	37.90	68.92	81.91	129.72	154.37	174.44	192.17
	0.00	0.00	0.00	0.01	0.01	0.19	0.69	2.20	7.89	7.10	6.67	41.37
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.57	2.83	2.31	22.07	0.00
Investments	3.42	3.29	0.00	0.00	0.00	0.10	19.54	19.61	19.54	19.88	25.07	79.51
	0.26	0.28	2.37	1.67	6.10	37.61	48.69	59.53	99.46	125.08	120.63	71.29
Total Assets	3.68	3.57	2.37	1.68	6.11	37.90	68.92	81.91	129.72	154.37	174.44	192.17

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.21	-0.03	-0.13	-0.68	-1.51	-14.37	13.46	8.89	-7.07	-1.83	-7.60	43.87
	-3.11	0.13	2.67	-0.01	-0.01	-0.28	-20.03	-6.87	-2.29	0.46	-24.98	-67.77
	2.38	-0.11	-0.24	0.00	0.00	18.10	3.49	-1.64	26.39	27.55	17.21	0.54
Net Cash Flow	-0.52	-0.02	2.30	-0.69	-1.51	3.44	-3.08	0.38	17.04	26.19	-15.37	-23.35
Free Cash Flow	0.21	-0.03	-0.13	-0.69	-1.52	-14.55	12.87	6.56	-9.44	-1.02	-27.39	30.54
CFO/OP	700%	50%	100%	88%	-97%	-158%	84%	84%	-10%	60%	-228%	5,996%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	30.42	0.00			146.81	249.73	202.23	187.78	264.25	399.11	538.13	289.83
Inventory Days						9.23	0.12	0.00	6.62	5.43	0.00	0.00
Days Payable						81.27	95.96		76.73	80.38
Cash Conversion Cycle	30.42	0.00			146.81	177.69	106.38	187.78	194.14	324.16	538.13	289.83
Working Capital Days	-669.17	-1,387.00			82.12	186.70	94.62	105.47	156.31	253.73	282.17	43.07
ROCE %	7.66%	-1.83%	-4.59%	-39.79%	96.25%	58.36%	55.40%	37.15%	27.93%	6.05%	5.06%	5.93%

Insights

In beta

Mar 2020

Mar 2021

Branded Generics Share of Pharma Product Mix
%

	xx
x
xx
	xxx
	xxx

Please log in to see hidden values.

Number of Countries of Operation (Existing Markets)
count

Number of Warehouses (Distribution Network)
count

Pharma Product Registrations (Approved)
count

Pharma Product Registrations in Pipeline (Submitted or Pending)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	71.22%	71.22%	66.86%	65.99%	65.99%	65.99%	65.99%	65.99%	65.99%	65.99%	65.99%	65.99%
	18.57%	18.57%	17.21%	16.88%	16.48%	16.48%	16.02%	8.87%	3.50%	1.74%	0.00%	0.00%
	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	2.56%	2.56%
	10.18%	10.18%	15.91%	17.11%	17.50%	17.50%	17.96%	25.12%	30.49%	32.24%	31.45%	31.45%
No. of Shareholders	5,047	5,045	5,206	6,586	7,863	8,529	9,994	13,737	14,620	15,085	15,176	14,682

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	73.23%	73.23%	72.86%	72.86%	72.86%	71.57%	66.86%	65.99%	65.99%	65.99%
	0.00%	0.00%	0.00%	0.00%	0.00%	18.66%	17.21%	16.02%	0.00%	0.00%
	0.09%	0.09%	19.04%	19.48%	19.31%	0.03%	0.02%	0.02%	2.56%	2.56%
	26.84%	26.49%	8.09%	7.66%	7.83%	9.75%	15.91%	17.96%	31.45%	31.45%
No. of Shareholders	450	450	589	2,636	3,988	4,859	5,206	9,994	15,176	14,682

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

Credit ratings

Concalls

May 2026

Transcript

AI Summary
PPT
Jan 2026

Transcript

AI Summary
PPT
Nov 2025

Transcript

AI Summary
PPT
Aug 2025

Transcript

AI Summary
PPT
Jun 2025

Transcript

AI Summary
PPT
Feb 2025

Transcript

AI Summary
PPT
Nov 2024

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
Nov 2023

Transcript

AI Summary
PPT
Aug 2023

Transcript

AI Summary
PPT
May 2023

Transcript

AI Summary
PPT
Feb 2023

Transcript

AI Summary
PPT
Jan 2023

Transcript

AI Summary
PPT
Nov 2022
Transcript
PPT
Nov 2022
Transcript PPT
Oct 2022

Transcript

AI Summary
PPT
Aug 2022
Transcript
PPT
Aug 2022
Transcript PPT
Aug 2022

Transcript

AI Summary
PPT
Jun 2022

Transcript

AI Summary
PPT
Jun 2022

Transcript

AI Summary
PPT
Feb 2022

Transcript

AI Summary
PPT
Nov 2021

Transcript

AI Summary
PPT
Jul 2021

Transcript

AI Summary
PPT
May 2021

Transcript

AI Summary
PPT
Feb 2021
Transcript PPT
Oct 2020

Transcript

AI Summary
PPT